Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

UPDATE 2-India battles record COVID surge as rallies, Hindu festival draw huge crowds

Published 16-04-2021, 11:59 am
AZN
-
PFE
-

* Deaths see highest single-day rise in seven months

* Politicians continue election rallies risking a further spike

* Govt to supply 17,000 tonnes medical oxygen to dozen states (Recasts)

By Neha Arora and Sachin Ravikumar

NEW DELHI/BENGALURU, April 16 (Reuters) - India battled a record surge in COVID-19 cases on Friday as hospitals ran out of oxygen and beds, while politicians held election rallies and hundreds of thousands of Hindu devotees attended a weeks-long festival, infuriating health officials.

A massive second wave of infections, second only to the United States in total, forced authorities to restrict movement of people in Mumbai, New Delhi and other cities amid growing calls for faster vaccination rollouts.

The 217,353 new cases reported by the health ministry on Friday marked the eighth record daily increase in the last nine days and took the total number of cases to nearly 14.3 million.

The United States has reported more than 31 million infections.

Deaths in India rose by 1,185 over the past 24 hours - the highest single-day rise in seven months - to reach a total of 174,308.

Experts have raised concerns about the spread of more contagious variants of the disease, particularly given widespread participation in religious festivals and political rallies. A Lancet study this month estimated that daily deaths in India could double by June.

Hundreds of thousands of ascetics and devout Hindus were gathered along the banks of the Ganges in the northern state of Uttarakhand after a mass dip during a religious festival on Wednesday, hoping to wash away their sins. Hundreds have tested positive.

In the capital Delhi, cases hit a record 16,699 overnight.

"It appears that more younger people have severe illness," said Giridhara Babu, an epidemiology professor at the Indian Institute of Public Health.

Health Minister Harsh Vardhan again blamed a "casual approach" for the unprecedented rise in cases, though his colleagues in Prime Minister Narendra Modi's ruling party were still addressing election rallies attended by tens of thousands with little evidence of masks or social distancing.

Home Minister Amit Shah, whose department oversees lockdown and other COVID rules, held a roadshow on an open-top vehicle through a crowded street seeking votes in the state of West Bengal.

Thousands of farmers protesting in the capital against new agricultural laws for months have vowed to continue with their around-the-clock sit-ins. speed with which the virus is spreading in our region (South Asia) is truly frightening," said Udaya Regmi, of the International Federation of Red Cross and Red Crescent Societies.

VACCINE PROGRAMME

The government said it would supply an estimated 17,000 tonnes of oxygen to a dozen states where the virus is surging, including western Maharashtra and Delhi.

Supplies of anti-viral drug Remdesivir are also being stepped up after reports of a widespread shortage. has so far injected 117 million vaccine doses, the highest globally after the United States and China, but that covers only a small fraction of its 1.35 billion people.

Vaccinations peaked at 4.5 million doses on April 5 but have since averaged about 3 million a day, according to government data, amid complaints about shortages from states. has shifted from being a mass vaccine exporter to an importer, having earlier rebuffed foreign drugmakers like Pfizer (NYSE:PFE) PFE.N . It will import Russia's Sputnik V vaccine starting this month to cover as many as 125 million people. on Thursday also gave approval to the Haffkine Institute in Maharashtra to begin producing homegrown Bharat Biotech's COVAXIN shot, and said its production capacity would be raised to nearly 100 million doses by September.

The country is currently administering COVAXIN and AstraZeneca's AZN.L vaccine, which is manufactured by the Serum Institute of India and branded Covishield.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Daily COVID-19 case load in Indian state of Uttarakhand Daily COVID-19 case load in Indian state of Uttarakhand

https://tmsnrt.rs/3e1x5YA Daily COVID-19 case load in Indian state of Uttarakhand Daily COVID-19 case load in Indian state of Uttarakhand

https://tmsnrt.rs/2Qt5uHC COVID-19 cases in major Indian cities COVID-19 cases in major Indian cities

https://tmsnrt.rs/2T2419j COVID-19 cases in major Indian cities COVID-19 cases in major Indian cities

https://tmsnrt.rs/3jYrpAc ANALYSIS-India shifts from mass vaccine exporter to importer, worrying the world

Super-spreader' erupts as devout Hindus throng Indian festival

Delhi COVID-19 cemetery running low on space as deaths mount

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.